TMEM183A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.963200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.630600E-01
Normal-vs-Stage2
8.262800E-01
Normal-vs-Stage3
4.843000E-01
Normal-vs-Stage4
3.715400E-01
Stage1-vs-Stage2
7.804400E-01
Stage1-vs-Stage3
3.535800E-01
Stage1-vs-Stage4
6.920400E-01
Stage2-vs-Stage3
1.753170E-01
Stage2-vs-Stage4
3.990800E-01
Stage3-vs-Stage4
1.985570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.581000E-01
Normal-vs-AfricanAmerican
7.193800E-01
Normal-vs-Asian
1.862440E-01
Caucasian-vs-AfricanAmerican
7.439800E-01
Caucasian-vs-Asian
4.176700E-03
AfricanAmerican-vs-Asian
1.571680E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.093400E-01
Normal-vs-Female
8.461800E-01
Male-vs-Female
2.812400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.023000E-01
Normal-vs-Age(41-60Yrs)
7.824200E-01
Normal-vs-Age(61-80Yrs)
9.530600E-01
Normal-vs-Age(81-100Yrs)
5.369400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.277830E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.437000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.842200E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.060200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.690000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.871000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.687200E-01
Normal-vs-Daily Drinker
9.736800E-01
Normal-vs-Weekly Drinker
4.794200E-01
Normal-vs-Occasional Drinker
4.053800E-01
Normal-vs-Social Drinker
8.657200E-01
Non Drinker-vs-Daily Drinker
8.798600E-01
Non Drinker-vs-Weekly Drinker
2.908800E-01
Non Drinker-vs-Occasional Drinker
1.659570E-01
Non Drinker-vs-Social Drinker
8.585800E-01
Daily Drinker-vs-Weekly Drinker
2.777000E-01
Daily Drinker-vs-Occasional Drinker
1.644200E-01
Daily Drinker-vs-Social Drinker
7.649000E-01
Weekly Drinker-vs-Occasional Drinker
8.178000E-01
Weekly Drinker-vs-Social Drinker
3.461800E-01
Occasional Drinker-vs-Social Drinker
2.224200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.401200E-01
Normal-vs-Grade 2
3.582500E-02
Normal-vs-Grade 3
4.747400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.018200E-03
Grade 1-vs-Grade 3
8.481200E-03
Grade 1-vs-Grade 4
2.401200E-01
Grade 2-vs-Grade 3
9.604200E-01
Grade 2-vs-Grade 4
3.582500E-02
Grade 3-vs-Grade 4
4.747400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.109600E-01
Normal-vs-NonDiabetic
8.163000E-01
Diabetic-vs-NonDiabetic
2.803800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.236200E-01
Normal-vs-NoPancreatitis
9.149800E-01
Pancreatitis-vs-NoPancreatitis
8.068200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.683200E-01
Normal-vs-N1
9.414200E-01
N0-vs-N1
2.693800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.003600E-01
Normal-vs-TP53-NonMutant
7.968600E-01
TP53-Mutant-vs-TP53-NonMutant
4.563000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
